Primary Sjogren's syndrome followed by chronic myelogenous leukemia: A case report with a ten year history

Journal of Dermatology

Volumn 25, Issue 7, 1998, Pages 460-464

  Minowa, Rui ^a   Miyagawa, Sachiko ^a   Fukumoto, Takaya ^a   Majima, Toshimasa ^a   Shimoyama, Taketo ^a   Fujimura, Yoshihiro ^a   Shirai, Toshihiko ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Bone marrow transplantation; Myelogenous leukemia; Sjogren's syndrome

Indexed keywords

ANTINUCLEAR ANTIBODY; BUSULFAN; CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE AGENT; SS A ANTIBODIES; SS-A ANTIBODIES;

ADULT; ARTICLE; AUTOIMMUNITY; BONE MARROW TRANSPLANTATION; CASE REPORT; CHRONIC DISEASE; CHRONIC MYELOID LEUKEMIA; FEMALE; GENOTYPE; GRAFT VERSUS HOST REACTION; HLA SYSTEM; HUMAN; RECIPIENT; SJOEGREN SYNDROME; STEM CELL; FATALITY; FOLLOW UP; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; MYELOID LEUKEMIA;

ADULT; ANTIBODIES, ANTINUCLEAR; BONE MARROW TRANSPLANTATION; BUSULFAN; CYCLOPHOSPHAMIDE; FATAL OUTCOME; FEMALE; FOLLOW-UP STUDIES; GRAFT VS HOST DISEASE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKEMIA, MYELOID, CHRONIC; LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE; SJOGREN'S SYNDROME; TRANSPLANTATION CONDITIONING;

EID: 0031594895     PISSN: 03852407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1346-8138.1998.tb02435.x     Document Type: Article

References (16)

1. Ikehara S, Kawamura M, Takao F, et al: Organ-specific and systemic autoimmune diseases orginate from defects in hematopoietic stem cells, Proc Natl Acad Sci USA, 87: 8341-8344, 1990.
2. Levite M, Zinger H, Zisman E, Reisner Y, Mozes E: Beneficial effects of bone marrow transplantation on the serological manifestations and kidney pathology of experimental systemic lupus erythematosus, Cell Immunol, 162: 138-145, 1995.
3. Lowenthal RM, Cohen ML, Atkinson K, Biggs JC: Apparent cure of rheumatoid arthritis by bone marrow transplantation, J Rheumatol, 20: 137-140, 1993.
4. Jacobs P, Vincent MD, Marteil RW: Prolonged remission of severe refractory rheumatoid arthritis following allogeneic bone marrow transplantation for drug-induced aplastic anemia, Bone Marrow Transplant, 1: 237-239, 1986.
5. Nelson JL, Torrez R, Louie FM, Choe OS, Storb R, Sullivan KM: Pre-existing autoimmune disease in patients wilh long term survival after allogeneic bone marrow transplantation, J Rheumatol, 24 (suppl 48): 23-29, 1997.
6. Homma M, Tojo T, Akizuki M, Yamagata H: Criteria for Sjögren's syndrome in Japan, Scand J Rheumatol, 61 (suppl): 26-27, 1986.
7. Shumin Wn, Shimizu N, Yoshiyama H, Mizugaki Y, Shinozaki F, Takada K: Association of Epstein-Barr Virus (EBV) with Sjögren's Syndrome, Am J Pathol, 149: 1511-1517, 1996.
8. Tateishi M, Saito I, Yamamoto K, Miyasaka N: Spontaneous production of Epstein-Barr Virus by B lymphoblastoid cell lines obtained from patients with Sjögren's syndrome, Arthritis Rheum, 36: 827-835, 1993.
9. Zulman J, Jaffe R, Talal N: Evidence that malignant lymphoma of Sjögren's syndrome is a monoclonal B-cell neoplasm, N Engl J Med, 299: 1215-1220, 1978.
10. Wilke WS, Tubbs RR, Bukowski RM, et al: T cell lymphoma occurring in Sjögren's syndrome, Arthritis Rheum, 27: 951-955, 1984.
11. Chevalier X, Gaulard P, Voisin M-C, Martigny J, Farcet J-P, Larget-Piet B: Peripheral T cell lymphoma with Sjögren's syndrome: A report with immunologic and genotypic studies, J Rheumatol, 18: 1744-1746, 1991.
12. Martin-Santos JM, Carretero L, Armentia A, Alonso E, Gil I: Hodgkin's disease occurring in primaiy Sjögren's syndrome, Ann Rheum Dis, 49: 646-647, 1990.
13. Vivancos J, Bosch X, Grau JM, Coca A, Font J: Development of Hodgkin's disease in the course of primary Sjögren's syndrome, Br J Rheumatol, 31: 561-563, 1992.
14. Baldwin JL, Storb R, Thomas ED, Mannik M: Bone marrow transplantation in patients with gold-induced marrow aplasia, Arthritis Rheum, 20: 1043-1048, 1977.
15. McKendry RJR, Huebsch L, Leclair B: Progression of rheumatoid arthritis following bone marrow transplantation, Arthritis Rheum, 39: 1246-1253, 1996.
16. Hosaka N, Nose M, Kyogoku M, et al: Thymus transplantation, a critical factor for correction of autoimmune disease in aging MRL/+ mice, Proc Natl Acad Sci USA, 93: 8558-8562, 1996.